Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/15/2021 27 3
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/14/2021 37 37
Remdesivir Approved by FDA Experimental Antiviral Dec/02/2020 48 4
Atazanavir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/26/2020 6 1
Indinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/26/2020 6 1
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Nov/26/2020 22 11
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Nov/25/2020 19 5
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/18/2020 10 0
Daptomycin Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/07/2020 1 0
Alarelin Potential treatment - theoretical effect Experimental Antiviral Sep/07/2020 1 0